Martingale Asset Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-6,640
Closed -$204K – 775
2024
Q4
$204K Buy
+6,640
New +$221K 0.01% 737
2023
Q1
– Sell
-13,303
Closed -$428K – 826
2022
Q4
$428K Buy
13,303
+5
+0% +$170 0.01% 651
2022
Q3
$476K Buy
13,298
+700
+6% +$29.1K 0.01% 632
2022
Q2
$518K Buy
12,598
+750
+6% +$36.4K 0.01% 635
2022
Q1
$687K Buy
11,848
+1,750
+17% +$95.7K 0.01% 571
2021
Q4
$595K Buy
10,098
+6,705
+198% +$407K 0.01% 607
2021
Q3
$207K Buy
+3,393
New +$199K ﹤0.01% 815
2021
Q1
– Sell
-6,062
Closed -$229K – 844
2020
Q4
$229K Sell
6,062
-29,500
-83% -$972K ﹤0.01% 807
2020
Q3
$1.16M Sell
35,562
-19,799
-36% -$838K 0.01% 587
2020
Q2
$2.51M Buy
+55,361
New +$2.83M 0.03% 461

Other funds holding ATEX

Martingale Asset Management's ATEX Position: Q1 2025 in Review

Martingale Asset Management sold out of Anterix (ATEX) in Q1 2025, closing a stake of 6,640 shares — an estimated $204K sold.

Martingale Asset Management first reported a position in ATEX in Q2 2020 and held it in 10 quarters. The position peaked at $2.51M in Q2 2020. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

  • Martingale Asset Management reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
  • Martingale Asset Management sold 6,640 Anterix shares in Q1 2025, an estimated $204K.
  • Martingale Asset Management first reported a position in Anterix in Q2 2020 and held it in 10 quarters.
  • Martingale Asset Management's Anterix position peaked at $2.51M in Q2 2020.
  • 128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on Martingale Asset Management's 13F filing for Q1 2025, filed 14 May 2025.